SIMCERE PHARMACEUTICAL GROUP, ADS
SCR
SCR was delisted on the 23rd of December, 2013.
20 hedge funds and large institutions have $20.1M invested in SIMCERE PHARMACEUTICAL GROUP, ADS in 2013 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 3 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
21% more capital invested
Capital invested by funds: $16.6M → $20.1M (+$3.43M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 21 → 20 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $389K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
+$1.67M |
| 2 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
+$1.07M |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$960K |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$185K |
| 5 |
Renaissance Technologies
New York
|
+$112K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$533K |
| 2 |
Two Sigma Investments
New York
|
-$99K |
| 3 |
U
UBS
Zurich,
Switzerland
|
-$9.99K |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$6.69K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$5.73K |
SCR Hedge Fund Activity: Q3 2013 in Review
20 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) for Q3 2013, worth a combined $20.1M — up 21% from $16.6M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of SCR and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 6 added.
The largest buyer was Pine River Capital Management, adding an estimated $1.67M. The largest seller was Invesco, exiting entirely with an estimated $533K sold.
- 20 institutional investors held SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) as of Q3 2013, down from 21 in Q2 2013.
- Funds reported $20.1M of SIMCERE PHARMACEUTICAL GROUP, ADS stock for Q3 2013, up 21% quarter-over-quarter.
- 2 funds opened new SIMCERE PHARMACEUTICAL GROUP, ADS positions in Q3 2013 and 3 closed out, a net change of -1 holder.
- The largest SIMCERE PHARMACEUTICAL GROUP, ADS buyer in Q3 2013 was Pine River Capital Management, an estimated $1.67M added.
- The largest SIMCERE PHARMACEUTICAL GROUP, ADS seller in Q3 2013 was Invesco, an estimated $533K sold.
Based on aggregated 13F filings for Q3 2013.